Glucosamine Stability via Separate Granulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for stabilizing glucosamine, such as coated tablets or anti-oxidants, fail to adequately address its hygroscopic nature and instability, leading to insufficient shelf life and presence of degradants in commercial products, which are not effectively detected by standard USP methods.
Innovation Solution
A composition and method involving separate granulation of glucosamine with disintegrants and binders, and calcium or other active ingredients, processed in an essentially dry state to enhance stability, preventing moisture uptake and maintaining glucosamine's acidic pH, thereby improving shelf stability and reducing degradant formation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If glucosamine is prepared in coated tablets or capsules with anti-oxidants, then oxidation of the amino group is reduced, but the hygroscopic nature of glucosamine is not addressed and shelf life remains insufficient
Solution Approach 1:
The patent segments the formulation into multiple functional components: glucosamine sulfate as the active ingredient, microcrystalline cellulose as a non-hygroscopic carrier, and magnesium stearate as a lubricant. This segmentation allows each component to perform its specific function without interfering with the stability of glucosamine, thereby resolving the contradiction between reducing oxidation and addressing hygroscopicity.
Solution Approach 2:
The patent introduces microcrystalline cellulose as an intermediary carrier that does not exhibit hygroscopic properties. This intermediary substance allows glucosamine to be formulated in a stable matrix that prevents moisture uptake while maintaining the integrity of the amino group, thus extending shelf life without compromising stability.
2Reliability
If glucosamine is formulated in low humidity environments to address hygroscopicity, then moisture uptake is reduced, but manufacturing complexity increases and shelf life remains practically insufficient
Solution Approach 1:
The patent changes the physical and chemical parameters of the formulation by selecting specific excipients with defined properties: microcrystalline cellulose with low moisture affinity and magnesium stearate with lubricating properties. This parameter optimization allows the formulation to be manufactured under standard humidity conditions while maintaining stability, thereby reducing manufacturing complexity without sacrificing shelf life.
3Ease of manufacture
If standard USP methods are used to test glucosamine stability, then testing is simple, but degradants are not effectively detected and true stability is not assessed
Solution Approach 1:
The patent replaces the standard USP HPLC method with LC-MS (liquid chromatography-mass spectrometry) for stability testing. This substitution maintains the simplicity of the testing workflow while dramatically improving measurement precision, enabling the detection of degradants that were previously undetectable. The LC-MS method provides both quantitative stability assessment and qualitative degradant identification.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach results in a highly stable oral dosage form with glucosamine retention of approximately 100% after 3 months at 40°C/75% relative humidity, with no detectable degradants, compared to co-granulation methods which show less than 80% retention and significant degradant presence.
Implementation Method 1
processed in an essentially dry state to enhance stability, preventing moisture uptake
Implementation Method 2
maintaining glucosamine's acidic pH, thereby improving shelf stability and reducing degradant formation
Data Source
AI summary
The present invention provides for compositions comprising glucosamine wherein the glucosamine has improved and/or enhanced stability. Additionally, the present invention provides for methods of stabilizing compositions for use in preparing an oral dosage form comprising glucosamine.